Not yet recruiting means the trial is registered but has not started
Liraglutide (Saxenda) had the lowest weight loss percentage among users
Patients with heart failure or kidney disease should follow their healthcare provider's specific fluid recommendations
Some people who inject too early report a period of intense appetite suppression followed by a stronger-than-usual return of hunger once the excess drug begins clearing
Clinical trials have tested weekly doses ranging from 1 mg to 12 mg, with gradual titration used to improve tolerability and minimize gastrointestinal side effects
Urgent medical attention is required for severe or persistent abdominal pain (especially if radiating to the back), persistent vomiting preventing adequate fluid intake, signs of dehydration, blood in vomit, black stools, or jaundice, as these may indicate serious conditions such as pancreatitis or gallbladder disease